Antivirals are to be used very cautiously in Covid Infection even in Adults. In Pediatric age the course of the disease is slightly different than adults

Hi!!!both these drugs have just passed through clinical trials that too only done in a smal group of ppl ...these are just like other monoclonal antibodies like to tocilizumab...studies claim on decreasing mortality...there is no clear mention on reducing the long term COVID effects..only kids above 12 can receive the drug..

Hi, casirivimab and imdevimab is administered together for the treatment of mild to moderate (COVID-19) in adults and pediatric patients above 12 years of age with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progressing to severe COVID-19 and/or hospitalization. Not for all children with covid 19 Only high risk group It is administered intravenously and has its own set of pros and cons.

you should  get  a teleconsultaion  for thus and detailed  discussion  about all the  available  treatment  protocols if need to  know.

Based on scientific information available children below age of 18 year don’t require anti viral treatment in mild to moderate disease condition. Majority of kids only get mild disease. I would not advice any medication without consultation with your peditrician.

This cocktail drug is new in Covid treatment...very difficult to ans....time will tell....but yes theoretically it helps